View in EDS HTML Full Text PDF Full Text

The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors.

Saved in:
Bibliographic Details
Title: The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors.
Authors: Gueble SE; Department of Therapeutic Radiology, Yale School of Medicine, P.O. Box 208040, HRT 134, New Haven, CT, 06520-8040, USA., Vasquez JC; Department of Pediatrics, Yale School of Medicine, New Haven, CT, 06520, USA., Bindra RS; Department of Therapeutic Radiology, Yale School of Medicine, P.O. Box 208040, HRT 134, New Haven, CT, 06520-8040, USA. ranjit.bindra@yale.edu.; Department of Pathology, Yale School of Medicine, New Haven, CT, 06520, USA. ranjit.bindra@yale.edu.
Source: Current treatment options in oncology [Curr Treat Options Oncol] 2022 Nov; Vol. 23 (11), pp. 1566-1589. Date of Electronic Publication: 2022 Oct 15.
Publication Type: Journal Article; Review
Journal Info: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36242713
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gueble+SE%22">Gueble SE</searchLink>; Department of Therapeutic Radiology, Yale School of Medicine, P.O. Box 208040, HRT 134, New Haven, CT, 06520-8040, USA.<br /><searchLink fieldCode="AU" term="%22Vasquez+JC%22">Vasquez JC</searchLink>; Department of Pediatrics, Yale School of Medicine, New Haven, CT, 06520, USA.<br /><searchLink fieldCode="AU" term="%22Bindra+RS%22">Bindra RS</searchLink>; Department of Therapeutic Radiology, Yale School of Medicine, P.O. Box 208040, HRT 134, New Haven, CT, 06520-8040, USA. ranjit.bindra@yale.edu.; Department of Pathology, Yale School of Medicine, New Haven, CT, 06520, USA. ranjit.bindra@yale.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100900946%22">Current treatment options in oncology</searchLink> [Curr Treat Options Oncol] 2022 Nov; Vol. 23 (11), pp. 1566-1589. <i>Date of Electronic Publication: </i>2022 Oct 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Current+Science%2C+Inc%22">Current Science, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100900946 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1534-6277 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215346277%22">15346277 </searchLink><i>NLM ISO Abbreviation: </i>Curr Treat Options Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36242713
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11864-022-01024-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1566
    Titles:
      – TitleFull: The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gueble SE
      – PersonEntity:
          Name:
            NameFull: Vasquez JC
      – PersonEntity:
          Name:
            NameFull: Bindra RS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2022 Nov
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1534-6277
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Current treatment options in oncology
              Type: main
ResultId 1